Celadon this week begins life as a listed company; the first company to be admitted to the London Stock Exchange AIM Market since the legalisation of cannabis-based medicinal products in 2018, and the first since GW Pharma. Governed by the UK regulators and trials underway targeting MHRA approval, we have ambitious plans to advance the …
Input your search keywords and press Enter.